Edison Scientific Hires Former Palantir Healthcare Leader Lewis Woolfson as Head of Forward Deployed Engineering
Edison Scientific Hires Former Palantir Healthcare Leader Lewis Woolfson as Head of Forward Deployed Engineering
NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Edison Scientific today announced the appointment of Lewis Woolfson, formerly Healthcare Lead at Palantir Technologies, as the company’s Head of Forward Deployed Engineering. Woolfson will lead the teams that embed Kosmos inside drugmakers’ R&D organizations, applying deep expertise putting AI to work across complex systems to grow Edison’s partnerships.
“One of the hardest parts of bringing AI into drug development is integrating it into all of the intricacies of how a company actually functions: its data, its processes and the way it makes decisions,” said Sam Rodriques, Ph.D., Chief Executive Officer of Edison Scientific. “That work is a big part of why our partners choose Edison. Lewis has spent years doing it inside some of healthcare’s most complex systems, and he’ll lead that effort as we grow.”
Woolfson brings extensive experience helping complex organizations deploy and scale AI solutions. At Palantir, he led large teams of Forward Deployed Engineers (FDEs) and oversaw deployments for major health systems in the United States and abroad, navigating an industry where strict privacy and safety requirements shape every rollout. Prior to joining Palantir, Woolfson worked in data science and analytics at PA Consulting. He began his career as a physicist, publishing research in Nature Photonics, and holds a Master’s degree in physics from the University of St Andrews.
“Kosmos is the most compelling platform I’ve seen for accelerating research, and with Edison’s exceptional team and growing partnerships, the company is at the frontier of AI for science,” said Woolfson. “What excites me most is the opportunity to bring Kosmos to the R&D teams discovering new medicines and to help transform how those medicines reach patients.”
The appointment comes as Edison expands its work with biopharma and research partners, including recent collaborations with Pfizer and Incyte. Woolfson will also serve as site lead for Edison’s growing New York City office, expanding both its FDE and Go-to-Market (GTM) capabilities.
“Embedding our FDE team with our customers is critical to the future of medicine discovery, and Lewis’s team is going to supercharge those efforts,” said William Passo, Head of Operations at Edison Scientific.
About Edison Scientific
Edison Scientific is building the AI platform for scientific research and development. Kosmos, Edison’s collaborative AI scientist, partners with R&D teams to support critical decisions and workflows, leverage their proprietary data, and bring innovations to market faster. Edison is a scientist-led company that was spun out of the nonprofit research lab FutureHouse in 2025, backed by $70M from Spark Capital, Triatomic Capital, and other investors.
To learn more, visit edisonscientific.com and follow the company on LinkedIn and X.
Contacts
Media Contact
Thermal for Edison Scientific
press@edisonscientific.com

